Study guide
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism
NBCRNA CRNA Certified Registered Nurse Anesthetist NCE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology
1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders
2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems
2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms
3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives
3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology
4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics
4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics
5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies
5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout
6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators
6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging
7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation
7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways
8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety
8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety
9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation
9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication
10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring
10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies
11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms
11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)
12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA
12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm
13 Chapter 13: Regional Anesthesia: Neuraxial Blocks
13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma
14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance
14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols
15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice
15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives
16 Chapter 16: Obstetric & Gynecologic Anesthesia
16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient
17 Chapter 17: Pediatric Anesthesia
17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm
18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia
18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols
19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia
19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction
20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation
21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology
21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements
22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology
22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices
23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures
23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases
24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control
24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure
25 Chapter 25: Neurosurgical Subspecialty Procedures
25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy
26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia
26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery
27 Chapter 27: Orthopedic & Extremity Anesthesia
27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block
28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy
28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia
29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients
29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism
Key Takeaways Explain This Topic AI
The Monro-Kellie doctrine dictates that the rigid cranial vault has a fixed total volume composed of brain parenchyma (~80%), blood (~10%), and cerebrospinal fluid (~10%); once compensatory displacement of CSF and venous blood is exhausted, intracranial compliance drops precipitously, causing exponential ICP spikes.
Cerebral Perfusion Pressure is calculated as CPP = MAP - ICP (or CVP, whichever is higher); normal CPP is 60 to 80 mmHg, autoregulated across MAP 50 to 150 mmHg, and critical cerebral ischemia occurs when CPP falls below 50 mmHg.
Acute reduction of elevated ICP (>20 mmHg) requires a tiered multimodal approach: transient mild hyperventilation (PaCO₂ 30-35 mmHg for 6-24 hours), osmotherapy (Mannitol 0.25-1.0 g/kg or 3% Hypertonic Saline to serum osmolarity <320 mOsm/L), head of bed elevation 30° with neutral neck alignment, CSF drainage via EVD, and CMRO₂ suppression with propofol or barbiturates.
Dexamethasone (4-10 mg IV) is highly effective for reducing vasogenic cerebral edema surrounding brain tumors by restoring capillary tight junctions, but is strictly contraindicated in traumatic brain injury (CRASH trial) and ischemic stroke.
Venous Air Embolism (VAE) in sitting craniotomies follows a strict detection sensitivity hierarchy: Transesophageal Echocardiography (TEE, 0.02 mL/kg) > Precordial Doppler (0.05 mL/kg, 'mill-wheel' murmur) > PAC > ETCO₂ drop / ETN₂ rise; immediate crisis management mandates flooding the surgical field, discontinuing N₂O, delivering 100% FiO₂, aspirating the multiorifice CVC, and placing the patient in Durant's position (left lateral Trendelenburg).
Last updated: August 2026
20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism
Neurosurgical anesthesia requires an uncompromising mastery of intracranial physiology, cerebral blood flow (CBF) autoregulation, cerebrospinal fluid (CSF) dynamics, and surgical positioning hazards. The anesthesia provider must actively maintain cerebral perfusion while preventing secondary brain injury from intracranial hypertension, herniation syndromes, or intraoperative venous air embolism (VAE).
1. The Monro-Kellie Doctrine & Intracranial Compliance
The intracranial vault is an inelastic, rigid bony enclosure containing three incompressible volumetric compartments: +-------------------------------------------------------------------------+
- | INTRACRANIAL VOLUMETRIC FRACTIONS |
- +------------------------------------+------------------------------------+
- | Compartment | Normal Percentage / Volume |
- +------------------------------------+------------------------------------+
- | **Brain Parenchyma** | ~80% (~1100 - 1200 mL) |
- | **Cerebrospinal Fluid (CSF)** | ~10% (~150 mL) |
- | **Intravascular Blood (CBV)** | ~10% (~150 mL: 70% venous, 30% art)|
+------------------------------------+------------------------------------+ Total Intracranial Volume = V Brain + V CSF + V Blood + V Mass = Constant \text{Total Intracranial Volume} = V_{\text{Brain}} + V_{\text{CSF}} + V_{\text{Blood}} + V_{\text{Mass}} = \text{Constant} Total Intracranial Volume = V Brain + V CSF + V Blood + V Mass = Constant [INTRACRANIAL ELASTANCE / COMPLIANCE CURVE]
- ICP (mmHg)
- ^
- 60 | / (Decompensation)
- | / Herniation Risk
- 40 | /
- | / Point of Decompensation
- 20 |----------------------------------------------* (ICP > 20 mmHg)
- | Compensated Phase /
- 0 +--------------------------------------------+---------------------->
- Intracranial Volume Expansion
- Spatial Compensation & Herniation Syndromes
When an expanding intracranial mass lesion (e.g., tumor, hematoma, edema) develops, intracranial pressure (ICP) initially remains normal ( 5 − 15 mmHg 5 - 15 \text{ mmHg} 5 − 15 mmHg ) through two primary compensatory mechanisms:
CSF Translocation & Absorption: Translocation of CSF out of the cranium into the compliant lumbosacral subarachnoid space and accelerated CSF absorption via arachnoid granulations.
Venous Blood Displacement: Compression and extrusion of low-pressure cerebral venous blood into the extracranial jugular venous system.
Once these compensatory reserves are exhausted ( the inflection point on the intracranial elastance curve ), intracranial compliance ( Δ V / Δ P \Delta V / \Delta P Δ V /Δ P ) drops to near zero. Any minor subsequent addition of volume (e.g., coughing, hypercapnia, tumor expansion) triggers an exponential spike in ICP ( > 20 − 25 mmHg >20 - 25 \text{ mmHg} > 20 − 25 mmHg ), precipitating brain tissue displacement across rigid dural partitions: +---------------------------------------------------------------------------------------------------------+
- | MAJOR CEREBRAL HERNIATION PATTERNS |
- +-----------------------+--------------------------------------+------------------------------------------+
- | Herniation Type | Anatomical Shift | Key Clinical Signs |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **Uncal (Transtentor-**| Medial temporal lobe (uncus) shifts | • Ipsilateral fixed dilated pupil (CN III|
- | **ial)** | over the free edge of tentorium | compression) & contralateral hemiparesis|
- +-----------------------+--------------------------------------+------------------------------------------+
- | **Subfalcine (Cingu-**| Cingulate gyrus herniates under the | • Compression of anterior cerebral artery|
- | **late)** | rigid falx cerebri | (ACA) → contralateral lower leg paresis|
- +-----------------------+--------------------------------------+------------------------------------------+
- | **Central Transtentor-| Downward displacement of thalamus / | • Progressive altered consciousness, bi- |
- | **ial** | brainstem through tentorial notch | lateral small reactive pupils → coma |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **Tonsillar** | Cerebellar tonsils herniate downward | • Medullary compression → Cushing triad, |
- | | through the foramen magnum | cardiorespiratory collapse, apneusis |
- +-----------------------+--------------------------------------+------------------------------------------+
NCE Clinical Key — Cushing's Triad: A late, life-threatening manifestation of extreme intracranial hypertension and brainstem ischemia characterized by:
- Systemic Hypertension (widened pulse pressure)
- Bradycardia (reflex response to high MAP via baroreceptors)
- Irregular Respirations / Apnea (medullary respiratory center distortion)
- 2. Cerebral Perfusion Pressure (CPP) & Cerebral Blood Flow (CBF)
Cerebral Perfusion Pressure ( C P P CPP CPP ) represents the effective pressure gradient driving blood flow through the cerebral vascular bed: C P P = M A P − I C P ( or M A P − C V P , whichever is higher ) CPP = MAP - ICP \quad (\text{or } MAP - CVP, \text{ whichever is higher}) CPP = M A P − I CP ( or M A P − C V P , whichever is higher )
Normal Range: 60 − 80 mmHg 60 - 80 \text{ mmHg} 60 − 80 mmHg
Critical Ischemic Threshold: C P P < 50 mmHg CPP < 50 \text{ mmHg} CPP < 50 mmHg (results in focal or global cerebral hypoperfusion and cellular energy failure)
Neurotrauma / TBI Target: Maintain C P P CPP CPP between 60 − 70 mmHg 60 - 70 \text{ mmHg} 60 − 70 mmHg +---------------------------------------------------------------------------------------------------------+
- | PHYSIOLOGY OF CEREBRAL BLOOD FLOW (CBF) |
- +-----------------------+--------------------------------------+------------------------------------------+
- | Parameter | Normal Value | Key Determinants & Regulatory Limits |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **Global CBF** | **50 mL / 100g / min** | • Accounts for ~15% of resting CO |
- | | (~750 mL/min total) | • Gray matter: 80 mL/100g/min; White: 20 |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **CMRO₂** | **3.0 - 3.8 mL O₂ / 100g / min** | • Accounts for ~20% of total body VO₂ |
- | | (~50 mL/min total) | • 60% electrophysiologic, 40% basal cell |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **Autoregulation MAP**| **50 - 150 mmHg** (CPP 50-150 mmHg) | • Shifted rightward in chronic hyperten- |
- | | | sion; abolished in trauma/infarction |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **PaCO₂ Reactivity** | **Linear between 20 - 80 mmHg** | • CBF changes by **1 - 2 mL/100g/min** |
- | | | **per 1 mmHg change in PaCO₂** |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **PaO₂ Reactivity** | Minimal effect at PaO₂ > 60 mmHg | • Precipitous exponential spike in CBF |
- | | | when **PaO₂ drops below 50 - 60 mmHg** |
+-----------------------+--------------------------------------+------------------------------------------+ [CEREBRAL BLOOD FLOW AUTOREGULATION CURVE]
- CBF (mL/100g/min)
- ^
- 100 | / (Exudation / Edema)
- | /
- 50 |------------------+=======================+ (Autoregulatory Plateau)
- | / (Ischemia) |
- 0 +----------------+-------------------------+---------------------->
- 0 50 150 200
- Mean Arterial Pressure (MAP, mmHg)
- Flow-Metabolism Coupling & Anesthetic Effects
Intact Coupling (Propofol, Barbiturates, Etomidate): Decrease cerebral metabolic rate of oxygen ( C M R O 2 CMRO_2 CMR O 2 ) and secondarily induce parallel cerebral vasoconstriction, decreasing C B F CBF CBF , cerebral blood volume ( C B V CBV CB V ), and I C P ICP I CP .
Uncoupling (Volatile Anesthetics > 1 MAC): Inhalational agents decrease C M R O 2 CMRO_2 CMR O 2 but simultaneously produce dose-dependent direct intrinsic cerebral vasodilation. Above 1.0 MAC 1.0 \text{ MAC} 1.0 MAC , intrinsic vasodilation overwhelms metabolic suppression, resulting in increased C B F CBF CBF , increased C B V CBV CB V , and increased I C P ICP I CP . Volatile agents also blunt autoregulation in a dose-dependent fashion ( > 1 − 1.5 MAC >1 - 1.5 \text{ MAC} > 1 − 1.5 MAC ).
Ketamine: Direct cerebral vasodilator and sympathomimetic that historically increases C M R O 2 CMRO_2 CMR O 2 , C B F CBF CBF , and I C P ICP I CP ; relative caution remains standard in patients with borderline intracranial compliance unless controlled ventilation is maintained.
3. Acute ICP Reduction Strategies: The Multimodal Toolkit
When intracranial pressure exceeds 20 mmHg 20 \text{ mmHg} 20 mmHg or the neurosurgeon reports a "tight brain" during craniotomy, immediate multimodal intervention is required. +---------------------------------------------------------------------------------------------------------+
- | TIERED ACUTE ICP REDUCTION INTERVENTIONS |
- +-----------------------+--------------------------------------+------------------------------------------+
- | Intervention | Mechanism of Action | Clinical Rules & Cautionary Traps |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **1. Hyperventilation**| • Lowers PaCO₂ → alkalosis of CSF → | • **Target PaCO₂ 30 - 35 mmHg** |
- | | arteriolar vasoconstriction → ↓CBV | • Effect lasts **6 to 24 hours** only |
- | | | • Avoid PaCO₂ <25 mmHg (severe ischemia) |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **2. Mannitol** | • Osmotic gradient across intact BBB | • Dose: **0.25 - 1.0 g/kg IV** over 20 m |
- | | draws water from brain parenchyma | • Onset: 15-30 min; Duration: 4-6 hours |
- | | • Reduces blood viscosity / ↑rheology| • Transient hypervolemia / CHF risk; |
- | | | hold if serum osmolarity **>320 mOsm** |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **3. 3% Hypertonic** | • Strong osmotic gradient across BBB | • Dose: **250 mL bolus** or 1-2 mL/kg/hr |
- | ** Saline (HTS)** | • Expands intravascular volume | • Target Serum Na: **145 - 155 mEq/L** |
- | | without inducing diuresis | • Ideal for hypovolemic/hypotensive TBI |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **4. Head of Bed 30°**| • Enhances jugular venous drainage | • Keep head/neck in **neutral midline** |
- | | via hydrostatic gravity gradient | • Flexion/rotation kinks internal jugular|
- +-----------------------+--------------------------------------+------------------------------------------+
- | **5. CSF Drainage** | • Direct volumetric withdrawal from | • External Ventricular Drain (EVD) |
- | | cerebral ventricular system | • Zeroed at **Foramen of Monro / Tragus**|
- +-----------------------+--------------------------------------+------------------------------------------+
- | **6. CMRO₂ Suppress-**| • Decreases neuronal metabolic demand| • Propofol or Barbiturate burst suppress |
- | ** ion (Barbs/Prop)**| coupled with arteriolar constriction| • Maintain MAP to prevent drop in CPP |
- +-----------------------+--------------------------------------+------------------------------------------+
- | **7. Dexamethasone** | • Repairs blood-brain barrier tight | • **4 - 10 mg IV** every 6 hours |
- | | junctions in **vasogenic edema** | • Indicated ONLY for **tumors/abscesses**|
- | | | • **CONTRAINDICATED in TBI & Stroke** |
- +-----------------------+--------------------------------------+------------------------------------------+
- Osmotherapy: Mannitol vs. Hypertonic Saline
Mannitol (0.25 to 1.0 g/kg IV): Requires an intact Blood-Brain Barrier (BBB). In areas with disrupted BBB, mannitol can penetrate the cerebral parenchyma, causing reverse osmotic shift and rebound edema upon discontinuation. Because it initially expands intravascular volume before producing massive osmotic diuresis, it can trigger flash pulmonary edema in patients with heart failure.
Hypertonic Saline (3%, 7.5%, 23.4% NaCl): Draws interstitial water into the vascular space while expanding plasma volume and maintaining systemic blood pressure (ideal for multitrauma/hypotensive brain-injured patients). Monitor serum sodium closely; avoid exceeding 155 − 160 mEq/L 155 - 160 \text{ mEq/L} 155 − 160 mEq/L or serum osmolarity > 320 mOsm/L >320 \text{ mOsm/L} > 320 mOsm/L .
Corticosteroid Rules: Vasogenic vs. Cytotoxic Edema
Vasogenic Edema: Breakdown of endothelial tight junctions allowing protein-rich plasma to extravasate into white matter (classically seen in brain neoplasms and abscesses). Highly responsive to Dexamethasone .
Cytotoxic Edema: Intracellular accumulation of water due to sodium-potassium ATPase pump failure (seen in traumatic brain injury, cardiac arrest, hypoxic-ischemic encephalopathy, and cerebral infarction). Corticosteroids are ineffective and strictly contraindicated in TBI —the landmark CRASH trial demonstrated increased 14-day mortality with methylprednisolone administration in acute TBI.
4. Venous Air Embolism (VAE) in Neurosurgery
Venous Air Embolism is a hazard of neurosurgical procedures where the operative site is positioned above the level of the right atrium (classically sitting craniotomies , posterior fossa explorations, cervical spine surgeries, and park-bench positions). +-------------------------------------------------------------------------+
- | PATHOPHYSIOLOGY OF VAE |
- +-------------------------------------------------------------------------+
- | 1. Non-collapsing Dural Venous Sinuses / Suboccipital Veins |
- | → Open vessel tethered by bone/dura cannot collapse |
- | 2. Negative Transmural Venous Pressure Gradient |
- | → Subatmospheric pressure entrains atmospheric air into veins |
- | 3. Air Bubbles Enter Superior Vena Cava → Right Atrium → Right Ventricle|
- | 4. Right Ventricular Outflow Tract (RVOT) "Mechanical Vapor Lock" |
- | → Massive increase in Pulmonary Vascular Resistance (PVR) |
- | → Acute Right Ventricular Strain / Failure and Low Cardiac Output |
- | 5. Ventilation-Perfusion Mismatch (Dead Space) |
- | → Alveoli ventilated but not perfused → Acute drop in ETCO₂ |
- | 6. Paradoxical Air Embolism (PAE) |
- | → Patent Foramen Ovale (PFO) allows air to cross to left atrium |
- | → Stroke / Myocardial Infarction |
+-------------------------------------------------------------------------+ [VAE MONITORING MODALITY SENSITIVITY HIERARCHY]
- Modality Sensitivity (Air Volume) Invasiveness
- +-----------------------------+------------------------------+---------------+
- | Transesophageal Echo (TEE) | **0.02 mL/kg** (Most Sens.) | Invasive |
- | Precordial Doppler | **0.05 mL/kg** | Non-Invasive |
- | Pulmonary Artery Catheter | **0.25 mL/kg** (↑ PAP) | Invasive |
- | End-Tidal CO₂ (ETCO₂) | **0.50 mL/kg** (Precipitous↓)| Non-Invasive |
- | End-Tidal Nitrogen (ETN₂) | **> 0.50 mL/kg** (Specific ↑)| Non-Invasive |
- | Esophageal Stethoscope | **> 1.0 - 2.0 mL/kg** (Late) | Non-Invasive |
- | Hemodynamic Collapse / EKG | **> 1.5 - 2.0 mL/kg** (Late) | Non-Invasive |
- +-----------------------------+------------------------------+---------------+
- Clinical Monitoring Pearls
Precordial Doppler: Placed over the 3rd to 6th intercostal space immediately to the right of the sternum (right atrium). Validated by injecting a 5 − 10 mL 5 - 10 \text{ mL} 5 − 10 mL agitated saline flush through a peripheral or central line to elicit a transient loud rushing "waterfall" sound. When air enters during surgery, it detects as little as 0.05 mL/kg 0.05 \text{ mL/kg} 0.05 mL/kg as an erratic, churning sound ("mill-wheel murmur").
Capnography Changes: ETCO₂ drops precipitously due to acute pulmonary dead space expansion and cardiogenic hypoperfusion. Simultaneously, end-tidal nitrogen (ETN₂) rises because insoluble nitrogen gas from entrained air diffuses into the alveoli. [VAE CRISIS MANAGEMENT ALGORITHM]
- [1. NOTIFY SURGEON IMMEDIATELY]
- Surgeon floods field with sterile saline
- Packs bone edges with bone wax to seal sinuses
- |
- v
- [2. DISCONTINUE NITROUS OXIDE (N₂O)]
- Switch to 100% FiO₂
- Prevents 300-400% air bubble expansion
- |
- v
- [3. ASPIRATE CENTRAL VENOUS CATHETER]
- Multiorifice Bunegin-Albin catheter
- Positioned 2 cm below cavoatrial junction
- |
- v
- [4. BILATERAL JUGULAR VEIN COMPRESSION]
- Raises cranial venous pressure to stop air entrainment
- Identifies bleeding site for surgeon
- |
- v
- [5. HEMODYNAMIC SUPPORT & RESUSCITATION]
- IV fluid bolus, Epinephrine, Vasopressors, Inotropes
- |
- v
- [6. DURANT'S MANEUVER (IF CARDIAC ARREST)]
- Place patient in **Left Lateral Trendelenburg Position**
- Air floats to RV apex, relieving RVOT vapor lock
NCE Exam Trap — Nitrous Oxide in Sitting Craniotomy: Nitrous oxide is 34 times more soluble in blood than nitrogen . If N₂O is present in the bloodstream when atmospheric air (containing 78% nitrogen) enters a vein, N₂O rapidly diffuses into the air bubble much faster than nitrogen can diffuse out. This expands the bubble volume by 300% to 400% , transforming a subclinical microembolism into a fatal right ventricular outflow tract obstruction. N₂O is strictly avoided in sitting neurosurgical procedures.